Flublok Quadrivalent Interactions
There are 304 drugs known to interact with Flublok Quadrivalent (influenza virus vaccine, inactivated), along with 4 disease interactions. Of the total drug interactions, 1 is major, 298 are moderate, and 5 are minor.
- View all 304 medications that may interact with Flublok Quadrivalent
- View Flublok Quadrivalent disease interactions (4)
Most frequently checked interactions
View interaction reports for Flublok Quadrivalent (influenza virus vaccine, inactivated) and the medicines listed below.
- albuterol
- alprazolam
- amitriptyline
- amlodipine
- amlodipine / hydrochlorothiazide / olmesartan
- Anoro Ellipta (umeclidinium / vilanterol)
- Boostrix (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- bupropion
- celecoxib
- clonazepam
- duloxetine
- famotidine
- fluconazole
- gabapentin
- GlipiZIDE XL (glipizide)
- measles virus vaccine / mumps virus vaccine / rubella virus vaccine
- metoprolol
- montelukast
- ondansetron
- Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA (Pfizer) vaccine)
- pramipexole
- Prevnar 20 (pneumococcal 20-valent conjugate vaccine)
- rosuvastatin
- sertraline
- Shingrix (zoster vaccine, recombinant)
- simvastatin
- solifenacin
- tizanidine
- valacyclovir
- Vitamin D3 (cholecalciferol)
Flublok Quadrivalent disease interactions
There are 4 disease interactions with Flublok Quadrivalent (influenza virus vaccine, inactivated) which include:
Report options
QR code containing a link to this page
More about Flublok Quadrivalent (influenza virus vaccine, inactivated)
- Flublok Quadrivalent consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.